Helix BioPharma Corp. | Balance Sheet
Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,493.00
6,980.00
6,792.00
3,654.00
897.00
366
Total Accounts Receivable
559.00
343.00
491.00
489.00
630.00
315
Other Current Assets
139.00
82.00
184.00
90.00
173.00
92
Total Current Assets
5,191.00
7,405.00
7,467.00
4,233.00
1,700.00
773
Net Property, Plant & Equipment
677.00
448.00
329.00
235.00
487.00
374
Total Assets
5,868.00
7,853.00
7,796.00
4,468.00
2,187.00
1,147
Accounts Payable
304.00
-
-
-
-
Other Current Liabilities
644.00
1,042.00
969.00
1,304.00
2,204.00
Total Current Liabilities
948.00
1,042.00
969.00
1,304.00
2,204.00
Total Liabilities
948.00
1,042.00
969.00
1,304.00
2,204.00
Common Equity (Total)
4,920.00
6,811.00
6,827.00
3,164.00
17.00
Total Shareholders' Equity
4,920.00
6,811.00
6,827.00
3,164.00
17.00
Total Equity
4,920.00
6,811.00
6,827.00
3,164.00
17.00
Liabilities & Shareholders' Equity
5,868.00
7,853.00
7,796.00
4,468.00
2,187.00
About Helix BioPharma
View Profile
